Watch the latest episode of focusIR Fireside Chats: Why Edinburgh Investment Trust Is Backing Turnaround Stocks for 2026 Growth. View here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSeeing Machines Regulatory News (SEE)

Share Price Information for Seeing Machines (SEE)

Share Price is delayed by 15 minutes
Get Live Data
4.40    0.00 (0.00%)
Bid:
4.40
Ask:
4.525
Spread: 0.125 (2.841%)
Market Cap: £211.18m
SEE Live PriceLast checked at - London Stock Exchange

Intraday Seeing Machines Share Chart

Seeing Machines inks additional Occula NPU licence

20 Apr 2022 07:00

RNS Number : 5954I
Seeing Machines Limited
20 April 2022
 

 

Seeing Machines Limited

 

20 April 2022

 

Seeing Machines inks additional Occula® NPU licence

 

Seeing Machines Limited (AIM: SEE, "Seeing Machines" or the "Company"), the advanced computer vision technology company that designs AI-powered operator monitoring systems to improve transport safety, has signed an IP licence agreement ("Agreement") for its Occula® Neural Processing Unit (NPU) with an additional US based semiconductor company.

 

Representing the second licence of its Occula® NPU into the automotive semiconductor ecosystem, this Agreement will target development of a single semiconductor product with the option to expand into a larger family of devices. The licence facilitates another fully hardware accelerated and optimised silicon platform, via the Occula® NPU, exclusively enabling Seeing Machines' leading e-DME (embedded Driver Monitoring Engine / software) in a cost, performance, and power optimised fashion for automotive driver, occupant, and interior monitoring applications.

 

Licensing the Occula® NPU is the third pillar of the Company's "three-pillar embedded product strategy", which also includes it's FOVIO Chip solution and e-DME Software offering, and represents Seeing Machines' strategic approach to meeting the fast-growing needs of the global automotive interior monitoring market.

 

Occula® is a unique, application specific NPU that has been specifically designed to enable highly efficient human detection and tracking. It is also capable of running optimised networks (such as MobileNet and Resnet) to allow for efficient execution of state-of-the-art multi-object single-shot detection, achieving maximum silicon utilisation and minimum cost of processing.

 

Paul McGlone, CEO of Seeing Machines commented: "This additional IP license is an important milestone for Seeing Machines. It represents more validation that our three-pillar, systems focused, strategy is fitting and supportive of the automotive industry as it evolves rapidly to meet regulatory and customer demand with additional safety and functional outcomes, while minimising cost, package space, and power.

 

"Occula is an important performance enabler for devices that employ it, and we expect it to continue to drive market share and revenue expansion for our FOVIO e-DME product offering. Seeing Machines will continue to innovate our algorithm pipeline in line with our Occula NPU to ensure we continue to offer the most sophisticated and efficient processing options to our customers."

 

Enquiries:

 

Seeing Machines Limited

+61 2 6103 4700

Paul McGlone - CEO

Sophie Nicoll - Corporate Communications

Stifel Nicolaus Europe Limited (Nominated Adviser and Broker)

+44 20 7710 7600

Alex Price

Nick Adams

Ross Poulley

Lionsgate Communications (Media Enquiries)

Jonathan Charles

+44 7791 892509

 

About Seeing Machines (AIM: SEE), a global company founded in 2000 and headquartered in Australia, is an industry leader in vision-based monitoring technology that enable machines to see, understand and assist people. Seeing Machines' technology portfolio of AI algorithms, embedded processing and optics, power products that need to deliver reliable real-time understanding of vehicle operators. The technology spans the critical measurement of where a driver is looking, through to classification of their cognitive state as it applies to accident risk. Reliable "driver state" measurement is the end-goal of Driver Monitoring Systems (DMS) technology. Seeing Machines develops DMS technology to drive safety for Automotive, Commercial Fleet, Off-road and Aviation. The company has offices in Australia, USA, Europe and Asia, and supplies technology solutions and services to industry leaders in each market vertical.

 

www.seeingmachines.com

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
MSCEAELNFENAEFA
Date   Source Headline
9th May 20227:00 amRNSSeeing Machines collaboration in optics technology
21st Apr 20227:00 amRNSCollaboration with leading systems supplier
20th Apr 20227:00 amRNSSeeing Machines inks additional Occula NPU licence
30th Mar 20227:00 amRNSHalf-year results and financial report
28th Feb 202211:45 amRNSDirector/PDMR Shareholding
24th Feb 20227:00 amRNSSeeing Machines, Air Ambulance Victoria contract
23rd Feb 20227:00 amRNSHalf year trading update
16th Feb 20229:00 amRNSHolding(s) in Company
24th Jan 20227:00 amRNSIIHS Implementation of New Safety Ratings
6th Jan 202212:30 pmRNSSeeing Machines & Qualcomm to demo at CES 2022
6th Jan 202210:01 amRNSAmbarella & Seeing Machines Collaboration
5th Jan 202211:02 amRNSOmniVision & Seeing Machines ASIC Collaboration
31st Dec 20217:00 amRNSWithdrawal from in-person attendance at CES 2022
23rd Dec 202110:30 amRNSIssue of Performance Rights
16th Dec 20218:30 amRNSResult of AGM
16th Dec 20217:00 amRNSLargest Driver & Occupant Monitoring System Award
15th Dec 20218:08 amRNSFY 2021 Annual Report
14th Dec 202110:30 amRNSDirector/PDMR Shareholding
13th Dec 202110:00 amRNSDirector/PDMR Shareholding
9th Dec 20219:15 amRNSDirector/PDMR Shareholding
6th Dec 202110:00 amRNSNotice of AGM
1st Dec 202112:15 pmRNSHolding(s) in Company
1st Dec 202112:00 pmRNSDirector/PDMR Shareholding
1st Dec 20217:00 amRNSTotal Voting Rights
26th Nov 202110:00 amRNSDirector/PDMR Shareholding
26th Nov 20219:48 amRNSDirector/PDMR Shareholding
24th Nov 202110:52 amRNSIssue of Equity
24th Nov 20217:00 amRNSYear End Results
23rd Nov 20217:00 amRNSResult of Fundraise
22nd Nov 20214:37 pmRNSRetail Offer via PrimaryBid
22nd Nov 20214:35 pmRNSProposed Fundraise to Raise a Minimum of US$40m
15th Nov 20217:00 amRNSCollins Aerospace & Seeing Machines Collaboration
10th Nov 20217:00 amRNSChange of Nominated Adviser
8th Nov 20217:00 amRNSBipartisan infrastructure legislation
2nd Nov 20217:00 amRNSInvestor Presentation
18th Oct 20217:37 amRNSNotice of Results
13th Oct 20217:00 amRNSSeeing Machines establishes European sales team
11th Oct 20217:00 amRNSGlobal Framework Agreement with Shell
23rd Sep 20212:00 pmRNSSeeing Machines unveils its Occula® NPU
16th Aug 20217:13 amRNSLeading software provider integrates Guardian
11th Aug 20217:00 amRNSBipartisan Senate legislation
10th Aug 20217:00 amRNSHolding(s) in Company
3rd Aug 20217:00 amRNSFY21 trading update
14th Jul 20218:27 amRNSSeeing Machines moves to SETS trading platform
7th Jul 20217:00 amRNSAgreement with Airservices Australia
5th Jul 202111:58 amRNSIssue of Shares and Total Voting Rights
30th Jun 20217:00 amRNSDirector/PDMR Shareholding
28th Jun 20212:42 pmRNSDirector/PDMR Shareholding
23rd Jun 20212:05 pmRNSDirector/PDMR Shareholding
17th Jun 20217:00 amRNSSEE DMS available across five new vehicle models

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.